Perceptive Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $426,720 - $717,359	-42,000 Reduced 10.96%	341,239 $4.76 Million
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $3.88 Million - $7.13 Million	-397,997 Reduced 50.94%	383,239 $6.61 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $920,062 - $1.29 Million	-68,764 Reduced 8.09%	781,236 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $3.42 Million - $5.92 Million	200,000 Added 30.77%	850,000 $14.9 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $3.81 Million - $18 Million	650,000 New	650,000 $16.4 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $145M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.